http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015351380-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e5c121269689cbab9b3a4548b15caf3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate | 2013-07-03^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00d3c0cf5d8b8cf33ee7e0c745153118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a85992e4e14a810c0f9b59217314ee24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce5d3e47345992e45024d95bb0c48f75 |
| publicationDate | 2015-12-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2015351380-A1 |
| titleOfInvention | Tissue-preserving liquid and tissue-preserving method |
| abstract | The present invention provides a tissue preservation solution that has good quality for preservation of tissues, organs and cells, and is useful in the fields of regenerative medicine, transplantation medicine, etc. The tissue preservation solution of the present invention comprises a compound having a Nrf2 activating effect. Preferable compounds having a Nrf2 activating effect are electrophiles, and in particular, ebselen and tert-butylhydroquinone. A preferable basal solution of the tissue preservation solution is Hank's balanced salt solution. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114181901-A |
| priorityDate | 2012-07-25^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 446 of 446.